Contact us on +022 2419 3000 or

Chronolife and Chugai Pharma to Create Smart Textiles

Jun 30, 2021
Chronolife and Chugai Pharma to Create Smart Textiles


Chronolife and the Chugai Pharma France laboratory aims to develop a smart textile for “real-life” monitoring of the impact of chronic pathologies on patients' articular health. The project has been initiated as part of the second season of the Digital Pharma Lab programme under the partnership between the two firms.

The purpose of this device is to enable remote assistance and diagnosis in order to promote the "continuum of care" between the hospital, the ambulatory and a patient's home. If successful, real-time processing of qualified alerts will enable rapid and appropriate therapeutic decisions to be made in the event of significant variations in the state of patients' joint health, with the aim to significantly improve their quality of life.

Chronolife designs and develops medical devices and customized digital connected health solutions to optimize diagnosis, monitoring and prediction of chronic pathologies. Founded in 2015 and based in Paris (France), with a presence in San Diego (USA), Chronolife was co-founded by iBionext, a unique ecosystem and investment fund dedicated to the creation, development and financing of innovative start-ups in the field of health technologies, and majority shareholder of Chronolife since its creation.

Founded in 1925 in Tokyo, Chugai Pharmaceutical Co., Ltd is one of Japan's leading biotechnology drug development and production laboratories. Its mission is to develop innovative drugs in areas where the medical needs of patients and the scientific community are still insufficiently covered.

Source: Businesswire

Also Read: